Vascular Biology |
From Cardiology, Cardiovascular Research (F.C., T.F.L.), University Hospital, Zürich, Switzerland; IRCCS Neuromed (F.C., M.V.), Pozzilli, Italy; Medical Chemistry and Biochemistry (E.R.W.), University of Innsbruck, Innsbruck, Austria; Neurochemistry (J.E.B., M.P.B., S.J.H.), Institute of Neurology, Queen Square, London, UK; Biochemistry (J.R.T.), Imperial College, London, UK; and Cardiovascular Medicine (N.W., K.M.C.), University of Oxford, Oxford, UK.
Correspondence to Thomas F. Lüscher, MD, FHRCP, Professor and Head of Cardiology, University Hospital, CH-8091 Zürich, Switzerland. E-mail cardiotfl{at}gmx.ch
Abstract(6R)-5,6,7,8-Tetrahydro-biopterin (H4B) is essential for the catalytic activity of all NO synthases. The hyperphenylalaninemic mouse mutant (hph-1) displays 90% deficiency of the GTP cyclohydrolase I, the rate-limiting enzyme in H4B synthesis. A relative shortage of H4B may shift the balance between endothelial NO synthase (eNOS)-catalyzed generation of NO and reactive oxygen species. Therefore, the hph-1 mouse represents a unique model to assess the effect of chronic H4B deficiency on endothelial function. Aortas from 8-week-old hph-1 and wild-type mice (C57BLxCBA) were compared. H4B levels were determined by high-performance liquid chromatography and NO synthase activity by [3H]citrulline assay in homogenized tissue. Superoxide production by the chemiluminescence method was measured. Isometric tension was continuously recorded. The intracellular levels of H4B as well as constitutive NO synthase activity were significantly lower in hph-1 compared with wild-type mice. Systolic blood pressure was increased in hph-1 mice. However, endothelium-dependent relaxations to acetylcholine were present in both groups and abolished by inhibition of NO synthase with NG-nitro-L-arginine methyl ester as well. Only in hph-1 mice were the relaxations inhibited by catalase and enhanced by superoxide dismutase. After incubation with exogenous H4B, the differences between the 2 groups disappeared. Our findings demonstrate that H4B deficiency leads to eNOS dysfunction with the formation of reactive oxygen species, which become mediators of endothelium-dependent relaxations. A decreased availability of H4B may favor an impaired activity of eNOS and thus contribute to the development of vascular diseases.
Key Words: NO synthase superoxide anion hydrogen peroxide catalase GTP cyclohydrolase I
This article has been cited by other articles:
![]() |
J. Belik, M. Jerkic, B. A. S. McIntyre, J. Pan, J. Leen, L. X. Yu, R. M. Henkelman, M. Toporsian, and M. Letarte Age-dependent endothelial nitric oxide synthase uncoupling in pulmonary arteries of endoglin heterozygous mice Am J Physiol Lung Cell Mol Physiol, December 1, 2009; 297(6): L1170 - L1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Moien-Afshari, S. Ghosh, S. Elmi, M. Khazaei, M. M. Rahman, N. Sallam, and I. Laher Exercise restores coronary vascular function independent of myogenic tone or hyperglycemic status in db/db mice Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1470 - H1480. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Z. Haque and D. S. A. Majid Reduced renal responses to nitric oxide synthase inhibition in mice lacking the gene for gp91phox subunit of NAD(P)H oxidase Am J Physiol Renal Physiol, September 1, 2008; 295(3): F758 - F764. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antoniades, C. Shirodaria, T. Van Assche, C. Cunnington, I. Tegeder, J. Lotsch, T. J. Guzik, P. Leeson, J. Diesch, D. Tousoulis, et al. GCH1 Haplotype Determines Vascular and Plasma Biopterin Availability in Coronary Artery Disease: Effects on Vascular Superoxide Production and Endothelial Function J. Am. Coll. Cardiol., July 8, 2008; 52(2): 158 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Cosentino, D Hurlimann, C Delli Gatti, R Chenevard, N Blau, N J Alp, K M Channon, M Eto, P Lerch, F Enseleit, et al. Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia Heart, April 1, 2008; 94(4): 487 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. H. Schulman, M.-S. Zhou, E. A. Jaimes, and L. Raij Dissociation between metabolic and vascular insulin resistance in aging Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H853 - H859. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Jackson, D. Pye, and J. Palomero The production of reactive oxygen and nitrogen species by skeletal muscle J Appl Physiol, April 1, 2007; 102(4): 1664 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Thengchaisri, R. Shipley, Y. Ren, J. Parker, and L. Kuo Exercise Training Restores Coronary Arteriolar Dilation to NOS Activation Distal to Coronary Artery Occlusion: Role of Hydrogen Peroxide Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 791 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Nurkiewicz and M. A. Boegehold High salt intake reduces endothelium-dependent dilation of mouse arterioles via superoxide anion generated from nitric oxide synthase Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1550 - R1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ardanaz and P. J. Pagano Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Experimental Biology and Medicine, March 1, 2006; 231(3): 237 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kopkan and D. S.A. Majid Enhanced Superoxide Activity Modulates Renal Function in NO-Deficient Hypertensive Rats Hypertension, March 1, 2006; 47(3): 568 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Mata-Greenwood, C. Jenkins, K. N. Farrow, G. G. Konduri, J. A. Russell, S. Lakshminrusimha, S. M. Black, and R. H. Steinhorn eNOS function is developmentally regulated: uncoupling of eNOS occurs postnatally Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L232 - L241. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-F. Lam, T. E. Peterson, D. M. Richardson, A. J. Croatt, L. V. d'Uscio, K. A. Nath, and Z. S. Katusic Increased blood flow causes coordinated upregulation of arterial eNOS and biosynthesis of tetrahydrobiopterin Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H786 - H793. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Bevers, B. Braam, J. A. Post, A. J. van Zonneveld, T. J. Rabelink, H. A. Koomans, M. C. Verhaar, and J. A. Joles Tetrahydrobiopterin, but Not L-Arginine, Decreases NO Synthase Uncoupling in Cells Expressing High Levels of Endothelial NO Synthase Hypertension, January 1, 2006; 47(1): 87 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Jackson Reactive oxygen species and redox-regulation of skeletal muscle adaptations to exercise Phil Trans R Soc B, December 29, 2005; 360(1464): 2285 - 2291. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Eskurza, L. A Myerburgh, Z. D Kahn, and D. R Seals Tetrahydrobiopterin augments endothelium-dependent dilatation in sedentary but not in habitually exercising older adults J. Physiol., November 1, 2005; 568(3): 1057 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cai Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences Cardiovasc Res, October 1, 2005; 68(1): 26 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kopkan and D. S. A. Majid Superoxide Contributes to Development of Salt Sensitivity and Hypertension Induced by Nitric Oxide Deficiency Hypertension, October 1, 2005; 46(4): 1026 - 1031. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Wang, S.-H. Li, R. D. Weisel, P. W. M. Fedak, A. Hung, R.-K. Li, V. Rao, K. Hyland, W.-J. Cherng, L. Errett, et al. Tetrahydrobiopterin deficiency exaggerates intimal hyperplasia after vascular injury Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R299 - R304. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Pritchard Jr, Y. Shi, and G. G. Konduri Tetrahydrobiopterin in Pulmonary Hypertension: Pulmonary Hypertension in Guanosine Triphosphate-Cyclohydrolase-Deficient Mice Circulation, April 26, 2005; 111(16): 2022 - 2024. [Full Text] [PDF] |
||||
![]() |
M. Nandi, A. Miller, R. Stidwill, T. S. Jacques, A. A.J. Lam, S. Haworth, S. Heales, and P. Vallance Pulmonary Hypertension in a GTP-Cyclohydrolase 1-Deficient Mouse Circulation, April 26, 2005; 111(16): 2086 - 2090. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Khoo, L. Zhao, N. J. Alp, J. K. Bendall, T. Nicoli, K. Rockett, M. R. Wilkins, and K. M. Channon Pivotal Role for Endothelial Tetrahydrobiopterin in Pulmonary Hypertension Circulation, April 26, 2005; 111(16): 2126 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Fortepiani and J. F. Reckelhoff Treatment with tetrahydrobiopterin reduces blood pressure in male SHR by reducing testosterone synthesis Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2005; 288(3): R733 - R736. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Alp and K. M. Channon Regulation of Endothelial Nitric Oxide Synthase by Tetrahydrobiopterin in Vascular Disease Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 413 - 420. [Abstract] [Full Text] |
||||
![]() |
J. Zhu, T. Mori, T. Huang, and J. H. Lombard Effect of high-salt diet on NO release and superoxide production in rat aorta Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H575 - H583. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Werner, A. C.F. Gorren, R. Heller, G. Werner-Felmayer, and B. Mayer Tetrahydrobiopterin and Nitric Oxide: Mechanistic and Pharmacological Aspects Experimental Biology and Medicine, December 1, 2003; 228(11): 1291 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Mitchell, A. M. Dorrance, and R. C. Webb GTP cyclohydrolase 1 inhibition attenuates vasodilation and increases blood pressure in rats Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2165 - H2170. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Zheng, X.-Q. Yang, K. J. Lookingland, G. D. Fink, C. Hesslinger, G. Kapatos, I. Kovesdi, and A. F. Chen Gene Transfer of Human Guanosine 5'-Triphosphate Cyclohydrolase I Restores Vascular Tetrahydrobiopterin Level and Endothelial Function in Low Renin Hypertension Circulation, September 9, 2003; 108(10): 1238 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Malo, F. Desjardins, J.-F. Tanguay, J.-C. Tardif, M. Carrier, and L. P. Perrault Tetrahydrobiopterin and antioxidants reverse the coronary endothelial dysfunction associated with left ventricular hypertrophy in a porcine model Cardiovasc Res, August 1, 2003; 59(2): 501 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yada, H. Shimokawa, O. Hiramatsu, T. Kajita, F. Shigeto, M. Goto, Y. Ogasawara, and F. Kajiya Hydrogen Peroxide, an Endogenous Endothelium-Derived Hyperpolarizing Factor, Plays an Important Role in Coronary Autoregulation In Vivo Circulation, February 25, 2003; 107(7): 1040 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Miura, J. J. Bosnjak, G. Ning, T. Saito, M. Miura, and D. D. Gutterman Role for Hydrogen Peroxide in Flow-Induced Dilation of Human Coronary Arterioles Circ. Res., February 7, 2003; 92 (2): e31 - e40. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vasquez-Vivar, D. Duquaine, J. Whitsett, B. Kalyanaraman, and S. Rajagopalan Altered Tetrahydrobiopterin Metabolism in Atherosclerosis: Implications for Use of Oxidized Tetrahydrobiopterin Analogues and Thiol Antioxidants Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1655 - 1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Panda, R. J. Rosenfeld, S. Ghosh, A. L. Meade, E. D. Getzoff, and D. J. Stuehr Distinct Dimer Interaction and Regulation in Nitric-oxide Synthase Types I, II, and III J. Biol. Chem., August 16, 2002; 277(34): 31020 - 31030. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Verma, A. Maitland, R. D. Weisel, P. W. M. Fedak, N. C. Pomroy, S.-H. Li, D. A. G. Mickle, R.-K. Li, and V. Rao Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1074 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Katusic Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H981 - H986. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. M. van Hinsbergh NO or H2O2 for Endothelium-Dependent Vasorelaxation : Tetrahydrobiopterin Makes the Difference Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 719 - 721. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |